Is low anti-Mullerian hormone (AMH) level a risk factor of miscarriage in women <37 years old undergoing in vitro fertilization (IVF)?

References

• Abu-Musa, A., Haahr, T., & Humaidan, P. (2020). Novel physiology and definition of poor ovarian response; Clinical recommendations. International Journal of Molecular Sciences, 21(6), 2110. https://doi.org/10.3390/ijms21062110
   Web of Science ®Google Scholar
• Alexopoulou, E., Pinborg, A., Budtz-Jørgensen, E., & Zedeler, A. (2019). Comparing early embryo morphokinetics with time-lapse microscopy in patients with low and normal ovarian response to ovarian stimulation. Reproductive Biology, 19(2), 127–132. https://doi.org/10.1016/j.repbio.2019.03.002
   PubMed Web of Science ®Google Scholar
• Aydin, G. A., Yavuz, A., Terzi, H., & Kutlu, T. (2015). Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSI. Iranian Journal of Reproductive Medicine, 13(4), 231–236. https://doi.org/10.36295/ASRO.2020.2342
   PubMedGoogle Scholar
• Bishop, L. A., Richter, K. S., Patounakis, G., Andriani, L., Moon, K., & Devine, K. (2017). Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients. Fertility and Sterility, 108(6), 980–987. https://doi.org/10.1016/j.fertnstert.2017.09.011
   PubMed Web of Science ®Google Scholar
• Broer, S. L., Broekmans, F. J., Laven, J. S., & Fauser, B. C. (2014). Anti-Müllerian hormone: Ovarian reserve testing and its potential clinical implications. Human Reproduction Update, 20(5), 688–701. https://doi.org/10.1093/humupd/dmu020
   PubMed Web of Science ®Google Scholar
• Chang, Y., Li, J., Li, X., Liu, H., & Liang, X. (2018). Egg quality and pregnancy outcome in young infertile women with diminished ovarian reserve. Medical Science Monitor, 24, 7279–7284. https://doi.org/10.12659/MSM.910410
   PubMed Web of Science ®Google Scholar
• Ciepiela, P., Dulęba, A. J., Kario, A., Chełstowski, K., Branecka-Woźniak, D., & Kurzawa, R. (2019). Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer. Human Reproduction, 34(11), 2244–2253. https://doi.org/10.1093/humrep/dez186
   PubMed Web of Science ®Google Scholar
• Cohen, J., Chabbert-Buffet, N., & Darai, E. (2015). Diminished ovarian reserve, premature ovarian failure, poor ovarian responder–a plea for universal definitions. Journal of Assisted Reproduction and Genetics, 32(12), 1709–1712. https://doi.org/10.1007/s10815-015-0595-y
   PubMed Web of Science ®Google Scholar
• Dewailly, D., Andersen, C. Y., Balen, A., Broekmans, F., Dilaver, N., Fanchin, R., Griesinger, G., Kelsey, T. W., La Marca, A., Lambalk, C., Mason, H., Nelson, S. M., Visser, J. A., Wallace, J. H., & Anderson, R. A. (2014). The physiology and clinical utility of anti-Mullerian hormone in women. Human Reproduction Update, 20(3), 370–385. https://doi.org/10.1093/humupd/dmt062
   PubMed Web of Science ®Google Scholar
• ESHRE Guideline Group on RPL, Bender Atik, R., Christiansen, O. B., Elson, J., Kolte, A. M., Lewis, S., Middeldorp, S., Nelen, W., Peramo, B., Quenby, S., Vermeulen, N., & Goddijn, M. (2018). ESHRE guideline: Recurrent pregnancy loss. Human Reproduction Open, 2018(2), hoy004. https://doi.org/10.1093/hropen/hoy004
   PubMedGoogle Scholar
• European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, Webber, L., Davies, M., Anderson, R., Bartlett, J., Braat, D., Cartwright, B., Cifkova, R., de Muinck Keizer-Schrama, S., Hogervorst, E., Janse, F., Liao, L., Vlaisavljevic, V., Zillikens, C., & Vermeulen, N. (2016). ESHRE Guideline: Management of women with premature ovarian insufficiency. Human Reproduction, 31(5), 926–937. https://doi.org/10.1093/humrep/dew027
   PubMed Web of Science ®Google Scholar
• Fanchin, R., Mendez Lozano, D. H., Frydman, N., Gougeon, A., di Clemente, N., Frydman, R., & Taieb, J. (2007). Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. The Journal of Clinical Endocrinology & Metabolism, 92(5), 1796–1802. https://doi.org/10.1210/jc.2006-1053
   PubMed Web of Science ®Google Scholar
• Greene, A. D., Patounakis, G., & Segars, J. H. (2014). Genetic associations with diminished ovarian reserve: A systematic review of the literature. Journal of Assisted Reproduction and Genetics, 31(8), 935–946. https://doi.org/10.1007/s10815-014-0257-5
   PubMed Web of Science ®Google Scholar
• Katz-Jaffe, M. G., Surrey, E. S., Minjarez, D. A., Gustofson, R. L., Stevens, J. M., & Schoolcraft, W. B. (2013). Association of abnormal ovarian reserve parameters with a higher incidence of aneuploid blastocysts. Obstetrics and Gynecology, 121(1), 71–77. https://doi.org/10.1097/aog.0b013e318278eeda
   PubMed Web of Science ®Google Scholar
• Kelsey, T. W., Wright, P., Nelson, S. M., Anderson, R. A., & Wallace, W. H. B. (2011). A validated model of serum anti-müllerian hormone from conception to menopause. PLoS One, 6(7), e22024. https://doi.org/10.1371/journal.pone.0022024
   PubMed Web of Science ®Google Scholar
• Lekamge, D. N., Barry, M., Kolo, M., Lane, M., Gilchrist, R. B., & Tremellen, K. P. (2007). Anti-Müllerian hormone as a predictor of IVF outcome. Reproductive Biomedicine Online, 14(5), 602–610. https://doi.org/10.1016/S1472-6483(10)61053-X
   PubMed Web of Science ®Google Scholar
• Levi, A. J., Raynault, M. F., Bergh, P. A., Drews, M. R., Miller, B. T., & Scott, R. T. (2001). Reproductive outcome in patients with diminished ovarian reserve. Fertility and Sterility, 76(4), 666–669. https://doi.org/10.1016/S0015-0282(01)02017-9
   PubMed Web of Science ®Google Scholar
• Lyttle Schumacher, B. M., Jukic, A. M. Z., & Steiner, A. Z. (2018). Antimüllerian hormone as a risk factor for miscarriage in naturally conceived pregnancies. Fertility and Sterility, 109(6), 1065–1071.e1. https://doi.org/10.1016/j.fertnstert.2018.01.039
   PubMed Web of Science ®Google Scholar
• McCormack, C. D., Leemaqz, S. Y., Furness, D. L., Dekker, G. A., & Roberts, C. T. (2019). Anti-Müllerian hormone levels in recurrent embryonic miscarriage patients are frequently abnormal, and may affect pregnancy outcomes. Journal of Obstetrics and Gynaecology, 39(5), 623–627. https://doi.org/10.1080/01443615.2018.1552669
   PubMed Web of Science ®Google Scholar
• Morin, S. J., Patounakis, G., Juneau, C. R., Neal, S. A., Scott, R. T., & Seli, E. (2018). Diminished ovarian reserve and poor response to stimulation in patients <38 years old: A quantitative but not qualitative reduction in performance. Human Reproduction, 33(8), 1489–1498. https://doi.org/10.1093/humrep/dey238
   PubMed Web of Science ®Google Scholar
• Neilson, J. P., Gyte, G. M., Hickey, M., Vazquez, J. C., & Dou, L. (2010). Medical treatments for incomplete miscarriage (less than 24 weeks). The Cochrane Database of Systematic Reviews, (1), CD007223. https://doi.org/10.1002/14651858.CD007223.pub2
   Google Scholar
• Nybo Andersen, A. M., Wohlfahrt, J., Christens, P., Olsen, J., & Melbye, M. (2000). Maternal age and fetal loss: Population based register linkage study. BMJ, 320(7251), 1708–1712. https://doi.org/10.1136/bmj.320.7251.1708
   PubMed Web of Science ®Google Scholar
• O’Brien, Y., Wingfield, M., & O’Shea, L. C. (2019). Anti-müllerian hormone and progesterone levels in human follicular fluid are predictors of embryonic development. Reproductive Biology and Endocrinology: RB&E, 17(1), 47. https://doi.org/10.1186/s12958-019-0492-9
   PubMedGoogle Scholar
• Pereira, N., Setton, R., Petrini, A. C., Lekovich, J. P., Elias, R. T., & Spandorfer, S. D. (2016). Is anti-Müllerian hormone associated with IVF outcomes in young patients with diminished ovarian reserve? Women’s Health, 12(2), 185–192. https://doi.org/10.2217/whe.15.102
   PubMedGoogle Scholar
• Peuranpää, P., Hautamäki, H., Halttunen-Nieminen, M., Hydén-Granskog, C., & Tiitinen, A. (2020). Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment. Human Reproduction, 35(3), 504–515. https://doi.org/10.1093/humrep/deaa008
   PubMed Web of Science ®Google Scholar
• Pils, S., Promberger, R., Springer, S., Joura, E., & Ott, J. (2016). Decreased ovarian reserve predicts inexplicability of recurrent miscarriage? A retrospective analysis. PLoS One, 11(9), e0161606. https://doi.org/10.1371/journal.pone.0161606
   PubMed Web of Science ®Google Scholar
• Shim, S. H., Ha, H. I., Jung, Y. W., Shim, S. S., Cho, Y. K., Kim, J. Y., Lee, K. J., Cha, D. H., Kim, S. H., & Park, H. J. (2015). Maternal antimullerian hormone as a predictor of fetal aneuploidy occurring in an early pregnancy loss. Obstetrics & Gynecology Science, 58(6), 494–500. https://doi.org/10.5468/ogs.2015.58.6.494
   PubMedGoogle Scholar
• Spandorfer, S. D., Davis, O. K., Barmat, L. I., Chung, P. H., & Rosenwaks, Z. (2004). Relationship between maternal age and aneuploidy in in vitro fertilization pregnancy loss. Fertility and Sterility, 81(5), 1265–1269. https://doi.org/10.1016/j.fertnstert.2003.09.057
   PubMed Web of Science ®Google Scholar
• Takahashi, C., Fujito, A., Kazuka, M., Sugiyama, R., Ito, H., & Isaka, K. (2008). Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization. Fertility and Sterility, 89(3), 586–591. https://doi.org/10.1016/j.fertnstert.2007.03.080
   PubMed Web of Science ®Google Scholar
• Tal, R., Tal, O., Seifer, B. J., & Seifer, D. B. (2015). Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: A systematic review and meta-analysis. Fertility and Sterility, 103(1), 119–130.e3. https://doi.org/10.1016/j.fertnstert.2014.09.041
   PubMed Web of Science ®Google Scholar
• Tarasconi, B., Tadros, T., Ayoubi, J. M., Belloc, S., de Ziegler, D., & Fanchin, R. (2017). Serum antimüllerian hormone levels are independently related to miscarriage rates after in vitro fertilization-embryo transfer. Fertility and Sterility, 108(3), 518–130.e3. https://doi.org/10.1016/j.fertnstert.2017.07.001
   PubMed Web of Science ®Google Scholar
• Thum, M. Y., Abdalla, H. I., & Taylor, D. (2008). Relationship between women’s age and basal follicle-stimulating hormone levels with aneuploidy risk in in vitro fertilization treatment. Fertility and Sterility, 90(2), 315–321. https://doi.org/10.1016/j.fertnstert.2007.06.063
   PubMed Web of Science ®Google Scholar
• Wang, A., Lathi, R., Kort, J., & Westphal, L. (2019). Anti-Müllerian hormone in association with euploid embryo transfer outcomes. Reproductive Biomedicine Online, 39(4), 609–616. https://doi.org/10.1016/j.rbmo.2019.05.006
   PubMed Web of Science ®Google Scholar
• Weghofer, A., Barad, D., Li, J., & Gleicher, N. (2007). Aneuploidy rates in embryos from women with prematurely declining ovarian function: A pilot study. Fertility and Sterility, 88(1), 90–94. https://doi.org/10.1016/j.fertnstert.2006.11.081
   PubMed Web of Science ®Google Scholar
• Zamah, A. M., Stephenson, M. D. (2018). Antimüllerian hormone and miscarriage: Fifty shades of gray…. Fertility and Sterility, 109(6), 1008–1009. https://doi.org/10.1016/j.fertnstert.2018.02.140
   PubMed Web of Science ®Google Scholar